| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $451.8M | +22.7% |
| Cost of Revenue | $123.0M | +14.8% |
| Gross Profit | $328.8M | +26.0% |
| R&D Expense | $150.6M | +21.5% |
| SG&A Expense | $98.8M | +5.6% |
| Operating Income | $12.2M | +173.1% |
| Pre-tax Income | -$30.1M | -31.5% |
| Income Tax | -$457.6M | — |
| Net Income | $424.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $177.3M | -20.0% |
| Short-term Investments | $78.1M | +4.9% |
| Accounts Receivable | $106.2M | +15.3% |
| Current Assets | $384.6M | -7.5% |
| Total Assets | $1.17B | +109.3% |
| Current Liabilities | $77.1M | -4.6% |
| Long-term Debt | $43.3M | -6.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $74.3M | -12.2% |
| Capital Expenditures | $5.3M | -6.5% |
| Investing Cash Flow | -$55.6M | +41.5% |
| Financing Cash Flow | -$61.7M | -219.7% |
| Free Cash Flow | $69.1M | -12.6% |
| +2062.3% |
| EPS (Basic) | $1.93 | +1854.5% |
| EPS (Diluted) | $1.68 | +1627.3% |
| Total Liabilities |
| $139.3M |
| -6.5% |
| Stockholders' Equity | $1.01B | +184.6% |